Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Details Textual)

v3.5.0.2
Description of Business and Summary of Significant Accounting Policies (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Aug. 31, 2015
Sep. 30, 2016
Oct. 13, 2016
Dec. 31, 2015
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Retained Earnings (Accumulated Deficit), Total   $ (3,251,407)   $ (748,360)
Cash, Uninsured Amount   $ 5,693,442    
Subsequent Event [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Certificates of Deposit, at Carrying Value     $ 3,000,000  
FDIC Insured Percentage     100.00%  
Due from Banks     $ 2,000,000  
Warrant [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   107,802    
Employee Stock Option [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   510,000    
Convertible Debt Securities [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   1,928,899    
Use Rights [Member] | AnnaMed, Inc [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Stock Issued During Period, Shares, Purchase of Assets 1,431,000      
Use Rights [Member] | IntertechBio Corporation [Member]        
Description Of Business And Summary Of Significant Accounting Policies [Line Items]        
Stock Issued During Period, Shares, Purchase of Assets 630,000